1. Home
  2. GOVX vs GVH Comparison

GOVX vs GVH Comparison

Compare GOVX & GVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

N/A

Current Price

$0.17

Market Cap

3.0M

Sector

Health Care

ML Signal

N/A

Logo Globavend Holdings Limited

GVH

Globavend Holdings Limited

N/A

Current Price

$0.90

Market Cap

2.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
GOVX
GVH
Founded
2001
2016
Country
United States
Australia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0M
2.6M
IPO Year
1996
2023

Fundamental Metrics

Financial Performance
Metric
GOVX
GVH
Price
$0.17
$0.90
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $10.00
N/A
AVG Volume (30 Days)
★ 111.0K
25.5K
Earning Date
11-12-2026
07-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $2,489,145.00
N/A
Revenue This Year
N/A
$1.85
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$0.74
Revenue Growth
N/A
★ N/A
52 Week Low
$0.17
$0.77
52 Week High
$1,425.00
$6.46

Technical Indicators

Market Signals
Indicator
GOVX
GVH
Relative Strength Index (RSI) 8.96 38.75
Support Level N/A $0.77
Resistance Level $8.64 $1.13
Average True Range (ATR) 0.16 0.07
MACD -0.15 0.00
Stochastic Oscillator 0.00 25.01

Price Performance

Historical Comparison
GOVX
GVH

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.

About GVH Globavend Holdings Limited

Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.

Share on Social Networks: